This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: University of Illinois. Active years: 2017-2018.
Company Filing History:
Years Active: 2017-2018
Title: Zhenjia Wang: Innovator in Neutrophil-Mediated Inflammatory Disease Treatment
Introduction
Zhenjia Wang is a prominent inventor based in Spokane, WA (US). He has made significant contributions to the field of medical research, particularly in the area of diagnosing and treating neutrophil-mediated inflammatory diseases. With a total of 2 patents, his work is paving the way for innovative therapeutic solutions.
Latest Patents
Zhenjia Wang's latest patents focus on compositions and methods for diagnosing or treating neutrophil-mediated inflammatory diseases. The disclosed nanoparticle compositions comprise nanoparticles prepared from denatured, cross-linked albumin and a therapeutic agent aimed at treating neutrophil-mediated inflammation. These compositions are designed to enhance the effectiveness of treatments for such inflammatory conditions.
Career Highlights
Zhenjia Wang is affiliated with the University of Illinois, where he continues to advance his research and innovation in the medical field. His work is characterized by a commitment to developing novel therapeutic strategies that address complex health issues.
Collaborations
Zhenjia Wang collaborates with esteemed colleagues, including Jaehyung Cho and Asrar B Malik. These partnerships enhance the scope and impact of his research, fostering a collaborative environment for innovation.
Conclusion
Zhenjia Wang is a dedicated inventor whose work in neutrophil-mediated inflammatory diseases is making a significant impact in the medical field. His innovative approaches and collaborations are essential in the pursuit of effective treatments for inflammatory conditions.